Abstract
The insulin secretory capacity was examined in diabetic children at the time of partial clinical remission during which their condition could be managed with low insulin therapy (<0.5 U insulin/kg body weight) and no urinary glucose excretion.
The extent of the residual beta cell function in 26 children was assessed either by an i.v. arginine test, a combined i.v. glucose-i.v. arginine test, a combined i.v. tolbutamide-i.v. arginine test, or a combined oral glucose-i.v. arginine test determining the C-peptide response by calculating the area under the curve above baseline levels. Two of the children were tested repeatedly.
Under the above conditions i.v. glucose and i.v. tolbutamide did not release C-peptide in diabetic children. In contrast, C-peptide secretion during arginine infusion following i.v. glucose or i.v. tolbutamide was siginficantly enhanced compared to the C-peptide secretion observed during arginine infusion alone. The C-peptide response to oral glucose was sluggish with no effect on the following arginine infusion.
The results indicate that during remission in juvenile onset diabetes i.v. glucose and i.v. tolbutamide without themselves being an appropriate signal for C-peptide release amplify the response to a subsequent arginine infusion under appropriate conditions.
Similar content being viewed by others
References
Akerblom HK (1980) Definition of a partial remission in insulin dependent, juvenile onset diabetes mellitus. Acta Pädiatr Belg 33:66
Ammon HPT, Grimm A, Lutz S, Wagner-Teschner D, Handel M, Hagenloch J (1980) Islet gluthatione and insulin release. Diabetes 29:830–834
Beischer W, Keller L, Mass M, Schiefer E, Pfeiffer EF (1976) Human C-peptide. Part I. Radioimmunoassay. Klin Wochenschr 54:709–711
Brown JC, Otte SC (1979) GiP and the entero-insular axis. Clin Endocrinol Metab 8/2:365–378
Campbell IL, Taylor KW (1982) The role of metabolism in the control of cyclic AMP efflux, cyclic AMP content and insulin secretion from rat islets of Langerhans. Biosci Rep 2:31–37
Cerasi E (1975) Potentiation of insulin release by glucose in man. Acta Endocrinol 79:502–510
Charles MA, Fauska R, Schmid FG, Forsham PH, Grodsky GM (1973) Adenosine 3′,5o-monophosphate in pancreatic islets: Glucose-induced insulin release. Science 179:569–571
Charles MA, Laweki J, Steiner AL, Grodsky GM (1976) Cyclic nucleotides in pancreatic islets. Tolbutamide-and arginineinduced insulin release. Diabetes 25:256–259
Edgar P, Rabinowitz D, Merimee TJ (1969) Effects of amino acids on insulin release from excised rabbit pancreas. Endocrinology 84:835–843
Faber OK, Binder C (1977) C-peptide response to glucagon. A test for the residual B-cell function in diabetes mellitus. Diabetes 26: 605–610
Heinze E, Steinke J (1972) Responses of isolated pancreatic islets of fetal, newborn and adult rats to theophylline and arginine. Horm Metab Res 4:234–236
Heinze E, Beischer W, Keller L, Winkler G, Teller WM, Pfeiffer EF (1978) C-peptide during the remission phase of juvenile diabetes. Diabetes 27:676–679
Huismann TH (1977) The hemoglobinopathies. Techniques of identification. In: Clinical and biochemical analysis, vol 6. Marcel Dekker, New York Basel, pp 126–131
Jackson RL, Onofrio J, Waiches H, Guthrie RA (1973) “The honey moon period” Partial remission of juvenile diabetes mellitus. Diabetes [Suppl 1] 22:361
Koncz L, Soeldner JS, Otto H, Smith TM, Gleason RE (1979) Insulin secretory dynamics after two consecutive intravenous stimulations with glucose and/or tolbutamide. Metabolism 28: 1183–1197
Levin SR, Karam JH, Hane S, Grodsky GM, Forsham PH (1971) Enhancement of arginine induced insulin secretion in man by prior administration of glucose. Diabetes 20:171–176
Ludvigson J, Heding LG (1977) C-peptide and juvenile diabetes. Acta Paediatr Scand [Suppl] 270:53–60
Mac Donald MJ, Ammon HPT, Pabel T, Steinke J (1974) Failure of 6-Aminonicothinamide to inhibit the potentiating effect of leucine and arginine on glucose induced insulin release in vitro. Diabetologia 10:761–765
Malaisse WJ, Hulton JC, Kowazu S, Herchnelz A, Valverde J, Seuer A (1979) The stimulus-secretion coupling of glucose-induced insulin release. Diabetologia 16:331–341
Menchini M, Meschi F, Lambiax R, Puzzovia M, Del Guerico MJ, Chiumello G (1980) C-peptide response to arginine stimulation in diabetic children. J Pediatr 96:362–366
Mirel RD, Ginsberg-Fellner F, Horwitz DL, Rayfield EJ (1980) C-peptide reserve in insulin-dependent diabetes. Diabetologia 19:183–188
Park BN, Soeldner JS, Gleason RE, (1974) Diabetes in remission. Insulin secretory dynamics. Diabetes 23:616–623
Pfeifer MA, Graf RJ, Halter JB, Porte D Jr (1981) The regulation of glucose-induced insulin secretion by pre-stimulus glucose level and tolbutamide in normal man. Diabetologia 21:198–205
Schauder P, Ahrends J, Schindler B, Ebert R, Frerichs H (1977) Permissive effect of glucose on the glucagon-induced accumulation of c AMP in isolated rat pancreatic islets. Diabetologia 13: 171–175
Verspohl EJ, Handel M, Ammon HPT (1979) Pentophosphate shunt activity of rat pancreatic islets. Its dependence on glucose concentration. Endocrinology 105:1269–1274
WHO (1980) Expert Committee on diabetes mellitus, second report. WHO, Geneva
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vetter, U., Heinze, E., Thon, A. et al. The effect of glucose, tolbutamide, and arginine on C-peptide release during remission in type I diabetes mellitus. Eur J Pediatr 140, 305–310 (1983). https://doi.org/10.1007/BF00442670
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00442670